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Abstract
Background: Most adults dying from falciparum malaria will die within 48 hours of their hospitalisation. An essential
component of early supportive care is the rapid identification of patients at greatest risk. In resource-poor settings, where
most patients with falciparum malaria are managed, decisions regarding patient care must frequently be made using clinical
evaluation alone.
Methods: We retrospectively analysed 4 studies of 1801 adults with severe falciparum malaria to determine whether the
presence of simple clinical findings might assist patient triage.
Results: If present on admission, shock, oligo-anuria, hypo- or hyperglycaemia, an increased respiratory rate, a decreased
Glasgow Coma Score and an absence of fever were independently predictive of death. The variables were used to construct
a simple clinical algorithm. When applied to the 1801 patients, this algorithm’s positive predictive value for survival to 48
hours was 99.4 (95% confidence interval (CI) 97.8–99.9) and for survival to discharge 96.9% (95% CI 94.3–98.5). In the 712
patients receiving artesunate, the algorithm’s positive predictive value for survival to 48 hours was 100% (95% CI 97.3–100)
and to discharge was 98.5% (95% CI 94.8–99.8).
Conclusions: Simple clinical findings are closely linked to the pathophysiology of severe falciparum malaria in adults. A basic
algorithm employing these indices can facilitate the triage of patients in settings where intensive care services are limited.
Patients classified as low-risk by this algorithm can be safely managed initially on a general ward whilst awaiting senior
clinical review and laboratory data.
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Introduction
Almost all patients with severe falciparum malaria will be
managed in a resource-poor setting without prompt access to
pathology and radiology services. While there are prognostic tools
to guide the management of adults with malaria, most require
laboratory data for calculation (table 1) [1,2,3].
The vital signs (temperature, blood pressure (BP), heart rate and
respiratory rate) are simple to measure and routinely recorded in
all hospitalisations. Other basic clinical indices, including level of
consciousness, oxygen saturation, blood glucose level (BGL) and
urine output have been proposed as additional ‘‘vital signs’’ [4].
Early recognition of a change in these clinical parameters can
promptly identify the deteriorating patient and may improve
outcomes [5,6]. Given the necessary emphasis on the clinical
assessment of adults with severe malaria in the resource-poor
setting, we examined whether such clinical indices might play a
role in patient triage and considered how they may reflect the
underlying pathophysiology of the disease.
Methods
Data was collected from all adults with strictly defined severe
falciparum malaria enrolled in studies published by our research
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unit between 1996 and 2013. These studies were SEAQUAMAT,
a multi-centre trial (n = 1050) comparing the efficacy of artesunate
and quinine [7]; a Vietnamese randomised clinical trial (n = 560)
comparing the efficacy of artemether and quinine [8]; a
Bangladeshi series (n = 163) examining the prediction of a
requirement for renal replacement therapy [9] (which consisted,
in turn, of patients enrolled in studies examining the efficacy of N-
acetylcysteine and levamisole as adjuvant therapy [10,11]); and
PRiSM, a Bangladeshi and Indian series (n = 28) that examined
fluid resuscitation [12]. All studies received prospective ethical
approval from the Oxford Tropical Research Ethics Committee
and local ethical bodies. Prospective written informed consent was
given by participants (or an attending caregiver) for their clinical
records to be used in the original studies. Although consent was
not specifically obtained for this retrospective review, all informa-
tion had been de-identified prior to its analysis.
Clinical Data
Study doctors collected the clinical data. Temperature was
measured using tympanic thermometers with fever defined as a
temperature $37.5uC and hypothermia as a temperature ,36uC.
Tachycardia was defined as a pulse rate $100 beats/minute and
bradycardia as ,60 beats/minute. BP was recorded using a
manual sphygmomanometer; mean arterial pressure (MAP) was
determined using the formula [(26diastolic BP)+systolic BP]/3.
Shock was defined as a systolic BP,80 mmHg with cool
peripheries. Tachypnoea was defined as an observed respiratory
rate $20 breaths/minute. Level of consciousness was determined
using the Glasgow Coma Scale (GCS). BGL was measured via
finger-prick using a glucometer, or from venous blood with a
point-of-care device (iStat, Abbott Laboratories); hypoglycaemia
was defined as a BGL ,3.5 mmol/L and hyperglycaemia as a
BGL $12 mmol/L. Oxygen saturation was recorded with pulse
oximetry. Oligo-anuria on admission was defined as a urine output
,10 ml in the first hour of hospitalisation after passage of a
urinary catheter.
Statistical Analysis
The relationship between death and the indices of temperature,
BP, heart rate, respiratory rate, level of consciousness, shock (yes/
no), BGL, oxygen saturation and oligo-anuria (yes/no) were
assessed using a Student’s t-test, the Mann-Whitney U test, or the
chi-squared test, as appropriate. To quantify the prognostic utility
of the clinical indices, multivariate logistic regression was
performed using a forward and backward stepwise approach,
with fatal outcome as the dependent variable. Only variables with
a value ,0.05 were retained in the final model. Oxygen saturation
was not included as a covariate in the multivariate model because
data were only available from the two smaller studies (n = 185).
Appropriate fit of the final model was confirmed using the
Hosmer-Lemeshow goodness-of-fit test after grouping the data by
predicted probabilities of death into 10 approximately equal-sized
groups. Visual inspection of the univariate relationships showed
that mortality increased as some of the variables approached both
their upper and lower limits. Therefore, fractional polynomials
were explored and included in the final model to allow for any
significant non-linear relationships. Predictors that remained in the
final model were also included in a random effects model to adjust
for any potential differences by study. All analyses were carried out
using statistical software (STATA, Version 10, StataCorp).
Results
A total of 1801 patients were enrolled in the four studies, their
baseline characteristics are presented in tables 2 and 3; 396 (22%)
died, 217 (12%) within 48 hours of their hospitalisation. 712
(39.5%) patients were treated with artesunate, 805 (44.7%) with
quinine and 284 (15.8%) with artemether.
Prognostic Value of Clinical Signs – Univariate Analysis
Temperature. Fever was present on admission in 1233/1794
(69%) (figure 1). Overall 20% (247/1233) of patients febrile at
enrolment died compared to 25.9% (145/561) of patients who
were afebrile (odds ratio (OR)= 0.72, (95% confidence interval
(CI)) 0.59–0.91; p = 0.006). This was despite the finding that
febrile patients had more severe disease as determined using the
RCAM score (p,0.001) (figure 2). Mortality was higher in
hypothermic patients (34.5%), but it was an infrequent finding (29
(1.6%) of 1794 observations) and the association did not reach
statistical significance (p= 0.11).
Heart rate. 72% (532/739) of patients were tachycardic on
enrolment and 3 (0.4%) bradycardic. Heart rate was associated
with outcome (p= 0.007), however this finding was strongly
influenced by the relatively few patients with a tachycardia $140
beats/minute (figure 1).
Blood pressure. Shock was not a common finding: 10.3%
(186/1800) of patients were shocked on admission, with 59 (32%)
dying compared with 21% (336/1614) of patients who were not
shocked (p = 0.001). Even with shocked patients included in the
analysis, mortality increased with rising MAP (p= 0.02) (figure 1).
MAP was inversely correlated with GCS (rs =20.22, p,0.001).
Respiratory rate. Tachypnoea was present in 1417/1796
(78.9%); mortality rose steadily with respiratory rate (p = 0.0001)
(figure 1).
Table 1. Prognostic tools used to predict outcome in adults
with severe malaria.
Score
Variable 0 (normal) 1 (abnormal)
2 (very
abnormal)
GCS 15 11–14 #10
Base Deficit ,2 2 to ,10 $10
Plasma bicarbonate $24 15 to ,24 ,15
Respiratory rate ,20 20 to ,40 $40
Malaria Score for Adults (MSA) [1]:
1 [severe anaemia (haemoglobin ,5 g/dL)]+2 [acute renal failure (serum
creatinine .3 mg/dl)]+3[Respiratory distress (respiratory failure requiring
ventilator)]+4 [cerebral malaria (unrousable coma)].
Malaria Prognostic Index (MPI) [2]:
4.5 (GCS ,5)+1.5 (GCS 5–11)+1(Parasitaemia .315,000/mL)+2.5 (Plasma lactate
.5 mmol/L)+1 (Serum bilirubin .58 mmol/L)+1.5 (Pigmented parasites
.20%)21.5 (Treatment with ACT).
Coma Acidosis Malaria (CAM) score [3]: MSA (0–10) is calculated using the
4 variables, classified as absent (0) or present (1) and multiplied by their
coefficients.
MPI (0–10) is calculated using the 5 variables, classified as absent (0) or present
(1) and multiplied by their coefficients.
CAM score (0–4) is calculated as the base deficit score (0–2) plus the Glasgow
Coma Score (GCS; 0–2). Bicarbonate-based CAM score (BCAM) (0–4) is
calculated as the bicarbonate score (0–2) plus the GCS (0–2). Respiratory
rate–based CAM score (RCAM) (0–4) is calculated as the respiratory rate
score (0–2) plus the GCS score (0–2).
doi:10.1371/journal.pone.0087020.t001
Clinical Findings in Adults with Severe Malaria
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Level of consciousness. 1239/1800 (68.8%) had impaired
consciousness (GCS,15) on admission. Mortality increased
steadily as GCS declined (p= 0.0001) (figure 1).
Blood glucose. There was a non-linear relationship between
BGL and death in univariate analysis (figure 1); this was the only
variable for which a fractional polynomial term was added to the
model (after which its relationship became statistically significant).
11.2% (199/1769) of patients were hypoglycaemic on admission,
68 (34%) of whom died. Patients hypoglycaemic on admission
were more likely to die than those with a normal BGL (3.5–
12 mmol/L) (OR (95% CI) 2.3 (1.7–3.2), p,0.001). Hypergly-
caemia was as common as hypoglycaemia and was associated with
Figure 1. Relationship between simple clinical indices at presentation and in-hospital mortality.
doi:10.1371/journal.pone.0087020.g001
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a similarly poor outcome: 32.8% (66/201) of patients hypergly-
caemic on admission died. Hyperglycaemic patients were also
more likely to die than those with normal admission BGL (OR:
2.2, 95% CI 1.6–3, p,0.001).
Pulse oximetry. Pulse oximetry was only routinely available
in the two smaller studies; however, in both oxygen saturation was
inversely associated with mortality (p = 0.01) (figure 1).
Oligo-anuria. Oligo-anuria was associated with an increased
requirement for renal replacement therapy (RRT) and greater
mortality. Patients in SEAQUAMAT had limited access to RRT,
which may have increased the associated mortality.
Multivariate Analysis
To determine which variables had independent prognostic
value, multivariate analysis was performed (table 4). Six indepen-
dent predictors of death were identified: temperature (OR 0.8;
95% CI 0.71–0.9), respiratory rate (OR 1.04; 95% CI 1.03–1.06),
GCS (OR 0.82; 95% CI 0.79–0.85), shock (OR 2.27; 95% CI
1.53–3.38) and oligo-anuria (OR 3.08; 95% CI 2.24–4.23); the
sixth independent predictor, BGL, had a non-linear relationship.
Use in Triage
The data were used to construct a clinical algorithm to identify
patients at greatest risk of dying (figure 3). Although there were
insufficient data to use oximetry in the multivariate model,
univariate analysis showed a strong association with mortality and
therefore it was incorporated into the algorithm. Conversely,
temperature was not employed as the absence of fever may also be
a sign of health. The algorithm’s six simple clinical indices were
shock, hypoxia (oxygen saturation #95%), abnormal BGL
(,3.5 mmol/L or $12 mmol/L), respiratory rate and GCS
(combined as a RCAM score with a cut-off at 2 (table 1)) and
oligo-anuria. Cut-offs were determined by inspection of the data
and extrapolation from common clinical practice. If data were
missing, the patient was assumed not to satisfy that criterion. In
applying the algorithm, the presence or absence of the signs was
determined sequentially, reflecting typical bedside evaluation
(figure 4).
Only 10/1801 (0.6%) patients without significant derangement
of one of the six indices on admission died prior to discharge and
only 2 (0.1%) died in the first 48 hours of their hospitalisation; 8
(80%) of the 10 deaths occurred in patients receiving inferior anti-
Figure 2. Relationship between fever and in-hospital mortality, stratified by disease severity (RCAM score). Febrile: tympanic
temperature $37.5uCelsius, RCAM: as defined and calculated in table 1.
doi:10.1371/journal.pone.0087020.g002
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Table 2. Baseline characteristics of the patients in the four studies.
SEAQUAMAT Vietnam Bangladesh PRiSM
Number 1050 560 163 28
Age Years 28 (21–40) 30 (22–40) 35 (23–45) 36 (24–45)
Male sex number (%) 787 (75) 425 (76) 130 (80) 19 (68)
Anti-malarial therapy 521 Artesunate 529
Quinine
284 Artemether
276 Quinine
163 Artesunate 28 Artesunate
Died before discharge number (%) 242 (23) 83 (14.8) 66 (40.5) 5 (17.8)
Died in the
1st 48 hours
number (%) 122 (50.4) 48 (57.8) 44 (66.7) 3 (60)
Temperature uCelsius 37.8 (37–38.9) 38.5 (37.5–39.5) 38 (37.1–38.9) 37.8 (37.1–38.5)
Shock number (%) 134 (12.8) 43 (7.7) 9 (5.6) 0
MAP mmHg 79.2 (69.3–89.1) 76.7 (70–86.7) 79.9 (73.2–90.2) 87.5 (79–100.2)
Heart Rate beats/minute * 104 (96–120) 108 (96–120) 102 (93–114)
Oxygen saturation % * * 96 (94–97) 98 (97–99)
Respiratory Rate breaths/minute 25 (20–32) 28 (24–32) 30 (26–36) 30 (26–36)
GCS 11 (8–15) 10 (8–15) 8 (6–11) 13 (8–15)
RCAM score 2 (1–3) 3 (1–3) 3 (3–3) 2 (1–3)
Glucose mmol/L 6.5 (5.4–8.3) 5 (3.6–7.3) 6.8 (5.3–10.1) 6.2 (5.7–9.9)
Oligo-anuric number (%) 205 (19.5) 44 (7.9) * 8 (28.6)
Peripheral
parasitaemia
parasites/mL 66.3 (10–238) 90 (17.8–340) 138 (33.7–357) 14.9 (4–446)
Blood Urea
Nitrogen
mmol/L 12.1 (7.1–24.3) 14.3 (7–27.1) 14.7 (9–26) 15 (11.4–24.5)
Creatinine mmol/L * 176 (128–300) 122 (79.6–202) 172 (105–273)
Lactate mmol/L * 3.4 (2.1–5) 4.7 (3.3–7.2) 3.1 (1.8–5)
Base deficit mmol/L 4 (1–9) 5 (2–8.9) 8 (3–12) 9 (7–13)
Haematocrit % 30 (22–36) 30 (24–36) 30 (24–36) 32 (25–38)
All numbers represent median (interquartile range) except where stated.
*Variable was not collected in this study.
MAP: Mean arterial pressure; mmHg: millimetres of mercury; GCS: Glasgow Coma Score; RCAM: Respiratory Coma Acidosis Malaria score; mmol/L: millimoles per litre;
mmol/L: micromoles per litre.
doi:10.1371/journal.pone.0087020.t002
Table 3. Simple clinical indices assessed in the studies and their association with survival to discharge.
Number of
observations All Survived n=1405 Died n=396 P
Temperature uC 1794 38 (37.2–39) 38 (37.2–39) 37.8 (37–38.9) 0.01
Shock number (%) 1800 186 (10.3) 127 (9) 59 (15) 0.001
MAP mmHg 1786 77.4 (69.3–87.4) 76.7 (69.3–86.7) 79.2 (69.3–90) 0.02
Heart Rate beats/minute 739 a 105 (96–120) 104 (95–120) 110 (104–124) 0.007
Oxygen saturation % 185 b 96 (94–98) 96 (94–98) 95 (92–97) 0.01
Respiratory Rate breaths/minute 1796 28 (22–32) 26 (22–32) 30 (24–36) 0.0001
GCS 1800 10 (8–15) 12 (8–15) 8 (6–11) 0.0001
RCAM score 1795 2 (1–3) 2 (1–3) 3 (2–3) 0.0001
Abnormal glucose number (%) 1769 400 (22.6) 266 (19.3) 134 (34.6) ,0.0001
Oligo-anuric number (%) 1638 c 257 (15.7) 155 (11.9) 102 (30.9) ,0.0001
All numbers represent median (interquartile range) except where stated.
aHeart rate was not recorded in SEAQUAMAT;
bOxygen saturation was only measured in the two smaller studies;
cOligo-anuria was not recorded in the Bangladeshi study. MAP: Mean arterial pressure; mmHg: millimetres of mercury; GCS: Glasgow Coma Score; RCAM: Respiratory
Coma Acidosis Malaria score;
doi:10.1371/journal.pone.0087020.t003
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malarial treatment (7 quinine, 1 artemether). Only 2/712 (0.3%)
patients receiving artesunate, without significant derangement of
one of the six indices on admission failed to survive to discharge;
these patients died on the third and fourth day of their
hospitalisation respectively. Thus simple clinical assessment on
admission, in patients receiving standard anti-malarial therapy
with artesunate, had a positive predictive value for survival at 48
hours of 100% (95% CI 97.3–100) and to discharge of 98.5%
(95% CI 94.8–99.8) (table 5).
A combination of an RCAM score ,2 and the presence of
oligo-anuria on admission identified 375/396 (94.7%) of deaths in
the series (figure 5); 17 of the 21 unidentified deaths occurred in
patients receiving inferior anti-malarial therapy and only 6 of the
21 died in the first 48 hours.
Table 4. Significant predictors of in-hospital mortality on multivariate analysis.
Odds ratio (95% CI) Odds ratio stratified by study* (95% CI)
Temperature 0.83 (0.73–0.94) 0.85 (0.75–0.97)
Respiratory rate 1.04 (1.02–1.06) 1.04 (1.02–1.06)
Glasgow Coma Score 0.82 (0.79–0.85) 0.82 (0.79–0.85)
Oligo-anuria 3.09 (2.23–4.28) 2.90 (2.09–4.04)
Shock 2.27 (1.53–3.38) 2.21 (1.48–3.28)
Glucose Non-linear relationship** Non-linear relationship**
Adjusted odds ratios (95% CI), n = 1602.
*Odds ratios from random effects model, stratified by study;
**Mortality increases with both evolving hypo and hyperglycaemia.
doi:10.1371/journal.pone.0087020.t004
Figure 3. Proposed initial triage strategy for an adult with falciparum malaria in a resource-poor setting. 1Shock: systolic blood
pressure ,80 mmHg with cool peripheries. 2Hypoxic: SaO2#95% using pulse oximetry.
3Abnormal blood glucose: blood glucose ,3.5 mmol/L or
$12 mmol/L using glucometer. 4RCAM (see table 1). 5Oligo-anuric: urine output ,10 ml first hour after catheterization.
doi:10.1371/journal.pone.0087020.g003
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The provision of supportive care was most completely
documented in SEAQUAMAT, although its availability was
sometimes limited reflecting the trial’s poor resource-setting. Pulse
oximetry was not routinely measured in SEAQUAMAT, but using
the algorithm’s remaining five criteria 217/1050 (21%) were
classified as low-risk; only 8 (3.7%) of these low-risk patients
required dialysis, mechanical ventilation or inotropic support at
any time during their hospitalisation compared with 150/833
(18%) of the high-risk patients (p,0.001).
Discussion
While not obviating the need for repeated evaluation and
confirmatory investigations, the presence of a few simple clinical
indices on presentation can accurately identify those at risk of a
complicated course, facilitating patient triage. Euglycaemic
patients with a RCAM score ,2, who are not shocked, hypoxic
or oligo-anuric on admission and who are treated with parenteral
artesunate are likely to have an excellent outcome and could safely
be managed initially on a general ward while senior clinical review
and laboratory data are awaited.
Coma, acidosis, and kidney injury have repeatedly been
demonstrated to be the three strongest prognostic factors in adults
Figure 4. Performance of the clinical algorithm in the four studies. *Both died .48 hours after enrolment.
doi:10.1371/journal.pone.0087020.g004
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with malaria [1,2,3]. Determination of their bedside correlates –
GCS, respiratory rate, and oligo-anuria – at presentation
identified almost 95% of the patients that would later die, a figure
rising to over 99% if shock, hypoxia or deranged BGL were added
to a clinical algorithm. Junior staff can perform this assessment at
the bedside rapidly, efficiently identifying the patients most in need
of care in a high-dependency setting.
Cerebral malaria is a striking syndrome and its implications for
management have been appropriately emphasised, however the
utility of a patient’s respiratory rate is generally underappreciated
Table 5. Ability of the clinical algorithm to predict survival to discharge (patient assessed at admission).
All patients Only patients receiving artesunate
Study Number Survival to discharge Survival to 48 h Number Survival to discharge Survival to 48 h
SEAQUAMAT 1050 96.8 (93.6–98.7) 99.6 (97.5–100) 521 98.4 (94.2–99.8) 100 (97.2–100)
Vietnam 560 96.6 (90.3–99.3) 98.8 (93.6–100) 0 n/a * n/a *
Bangladesh 163 100 (71.5–100) 100 (71.5–100) 163 100 (71.5–100) 100 (71.5–100)
PRiSM 28 100 (29.2–100) 100 (29.2–100) 28 100 (29.2–100) 100 (29.2–100)
Pooled 1801 96.9 (94.3–98.5) 99.4 (97.8–99.9) 712 98.5 (94.8–99.8) 100 (97.3–100)
All numbers represent the positive prediction value and 95% confidence interval.
*No patient received artesunate in this trial.
doi:10.1371/journal.pone.0087020.t005
Figure 5. Relationship between oligo-anuria and in-hospital mortality, stratified by disease severity (RCAM score). RCAM: as defined
and calculated in table 1. Oligo-anuric: urine output ,10 ml first hour after catheterization.
doi:10.1371/journal.pone.0087020.g005
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[13]. While respiratory distress is a World Health Organization
(WHO) criterion for severe malaria, this focuses on the increased
work of breathing seen predominantly in African children [14],
rather than on the respiratory rate itself. Tachypnoea may indicate
an underlying lactic acidosis or denote the important clinical
syndromes of pulmonary oedema and aspiration pneumonia [15].
Acute kidney injury (AKI) occurs in up to half of adults with
severe malaria, about a third of which is non-oliguric [9,16].
Anuric AKI suggests established acute tubular necrosis and is
frequently associated with late presentation and multi-system
disease [12,17]; less than 10% of anuric AKI responds to fluid and
anti-malarial therapy. Here oligo-anuria was independently
associated with a threefold increase in mortality. Promptly
recognising cases of AKI that will not respond to simple measures
expedites referral for RRT, which if delayed results in poorer
outcomes [17].
The pattern of the clinical findings’ disturbance also provides
insight into the pathophysiology of falciparum malaria, with
potential implications for management. In the current series,
patients who were febrile on admission were more likely to survive
than afebrile patients, an observation that persisted in multivariate
analysis. This was not the result of a harmful effect of hypothermia
(which was infrequently seen) and echoes the findings in a series of
988 adults with severe malaria where the mean temperature on
enrolment was also significantly higher in survivors [2]. This raises
the possibility that fever may be a protective, adaptive response in
severe malaria, as has been suggested by some, but not all, studies
of severe bacterial sepsis [18,19]. While an in vitro study showed
that higher temperatures increased the cytoadherence of parasit-
ised erythrocytes to vascular endothelium (the mechanism of
sequestration) [20], other studies have shown that higher
temperatures suppress parasite growth [21,22]. African children
with falciparum malaria receiving rectal paracetamol had a
reduced cytokine response and a prolonged parasite clearance
time, although the low dose used in this study (10–15 mg/kg, 6
hourly) may not have yielded therapeutic blood concentrations
[23]. Since the classic fever pattern in malaria is periodic, the
timing of a patient’s presentation influences their temperature on
admission. Schizogony leads to fever and profound malaise and
may precipitate the presentation of patients with milder disease
[24]. However, this association is lost in severe disease and as these
studies only enrolled patients meeting criteria for severe malaria
this would not explain our findings; indeed the febrile patients
actually had higher RCAM scores.
Young children have a high risk of febrile convulsions and
require anti-pyretic treatment. In these studies anti-pyretic
administration was incompletely documented precluding any
conclusions; however the retrospective finding that febrile adults
had a reduced case fatality rate warrants prospective investigation.
Studies to define the role of paracetamol in severe malaria are
ongoing (NCT01641289).
There are stark pathophysiological differences between malaria
and bacterial infection. Shock is a relatively infrequent finding in
patients with malaria compared to bacterial sepsis. Indeed shocked
malaria patients are often demonstrated to have bacterial co-
infection when sophisticated microbiological testing is available
[25]. While hypotension helps define sepsis and is a powerful
negative prognostic indicator [26], less than 20% of the patients in
these four studies had an admission MAP,65 mmHg and
mortality actually increased with rising MAP, similar to the
findings in another series of Asian adults with falciparum malaria
[2].
Why would higher – but by no means dangerously elevated –
BP be associated with a poorer outcome? In PRiSM, MAP was
.65 mmHg in 85% of patients despite the fact that all were
concurrently hypovolaemic, some profoundly so [27]. The degree
of microvascular sequestration – the pathological signature of
falciparum malaria linked to outcome and organ failure -
correlated with both the MAP and the systemic vascular
resistance, most likely via an indirect mechanism of endothelial
dysfunction and loss of vasodilatory tone [28]. The haemolysis
seen in malaria results in the release of free haemoglobin leading to
nitric oxide quenching which may exacerbate endothelial
dysfunction [29].
These findings have implications for management: unlike
bacterial sepsis, a ‘‘normal’’ BP in patients with severe malaria is
not reassuring. Moreover, in contrast to severe sepsis where a key
goal of resuscitation is fluid loading and inotropic support to
maintain a MAP of .65 mmHg [26], the fact that most patients
with severe malaria have a preserved BP supports a more
conservative approach to rehydration, especially as liberal fluid
loading is unequivocally harmful in this population, and has a
limited effect on microvascular obstruction [12,30].
The WHO uses hypoglycaemia to define severe malaria and its
recognition and management is appropriately highlighted: a low
BGL can be rapidly fatal, but has a simple remedy. In these studies
many patients received treatment with quinine, an insulin
secretagogue, before study enrolment. Hypoglycaemia was there-
fore common and was associated, as expected, with high mortality
(although notably mortality remained elevated with hypoglycae-
mia up to 3.5 mmol/L, above the present WHO cut-off of
2.2 mmol/L [31]). However hyperglycaemia at presentation was
equally common and was associated with a similar mortality.
Some comatose patients may have received a glucose bolus prior
to enrolment, as is recommended in settings where a BGL is not
immediately available [31]. Yet controlling for GCS in multivar-
iate analysis, mortality was still higher in hyperglycaemic patients,
suggesting that, as in other critical care settings, this is a genuine
association [32,33].
In one study intensified insulin therapy reduced the mortality of
critically ill hyperglycaemic surgical patients [34], although this
strategy led to frequent severe hypoglycaemia in patients with
bacterial sepsis [35] and increased mortality in a general ICU
population [36]. While hyperglycaemia may exacerbate fluid and
electrolyte depletion and have a negative effect on endothelial,
immune and neurological function [37,38,39], some argue that by
allowing vital tissues to utilise glucose independent of insulin some
degree of permissive hyperglycaemia may be beneficial [40]. As
artesunate replaces quinine as first-line anti-malarial therapy, the
incidence of hypoglycaemia will decline, particularly in adults who
experience the complication less frequently than children. With
the emerging Asian diabetes epidemic, the recognition and
management of hyperglycaemia - although more complicated -
may become just as relevant. A prospective study may resolve the
issue.
Our retrospective analysis has limitations. Although several
clinical indices are emphasised, clearly laboratory and radiological
investigations remain essential for optimal patient management.
Similarly, the utility of selected clinical findings does not obviate
the need for a detailed history and physical examination to identify
other co-morbidities. Our analysis uses clinical findings present at
admission which need to be followed sequentially; normal initial
values do not preclude the possibility of subsequent complications.
However it is noteworthy that while the ensuing medical care
provided in the studies was not evaluated in detail, patients
categorised as low-risk rarely required an escalation of care. The
relative prominence of prognostic indicators in adults with severe
malaria varies in different studies – this is related mainly to
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differences in the proportion of patients with severe disease, and
definitions of severe disease, in different cohorts. In this series, only
patients already enrolled in severe malaria studies were analysed,
accordingly the proposed algorithm re-classified only 18% patients
as low-risk; in a series of patients with milder disease an RCAM
,2 alone had a PPV for survival to discharge of 98.4% [2].
Finally, these findings cannot be directly extrapolated to the
paediatric population with malaria, although as the prognostic
indicators are comparable, trends are likely to be similar [41].
Conclusions
Clinical assessment of adults with falciparum malaria on
admission to hospital, focusing on a few simple indices, is able to
promptly identify those at risk of a complicated course, facilitating
their triage to a high dependency setting. A clinical emphasis is
more practical for health care workers who manage these patients
in the resource-poor setting and can help guide management while
more sophisticated assessment is awaited.
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